COMPOUND 21 ( DrugBank: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
85	特発性間質性肺炎	1

85. 特発性間質性肺炎

臨床試験数 : 627 / 薬物数 : 443 - (DrugBank : 120) / 標的遺伝子数 : 99 - 標的パスウェイ数 : 212

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2017-004923-63-GB (EUCTR)	10/07/2018	20/12/2017	A study to test the safety, tolerability, and the effects of C21 in patients with Idiopathic Pulmona ...	A phase 2, multi-center, randomized, double-blind, placebo-controlled, parallel-group study to inves ...	Idiopathic Pulmonary Fibrosis (IPF) MedDRA version: 20.0;Level: PT;Classification code 10021240;Term ...	Product Name: C21 INN or Proposed INN: PD00377 Na-salt Other descriptive name: COMPOUND 21	Vicore Pharma AB	NULL	Not Recruiting			Female: yes Male: yes	30	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): yes Therapeutic confirmatory - ( ...	Serbia;Poland;Bulgaria;United Kingdom

First Previous1Next Last